Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures
Completed
Depomed
Phase 1
2013-02-01
The purpose of this study is to assess the safety and efficacy of intranasally-administrated
fentanyl pectin spray (Lazanda®)given to decrease the pain during cystoscopy (the passage of
a telescopic instrument into the bladder for purpose of diagnosing the cause of blood in the
urine, urinary complaints or any other problems with the urinary bladder). The current
standard practice is to use Lidocaine jelly (a local anesthetic) given through the urethra to
lubricate and decrease local pain. In this study, an additional medicine (Lazanda®) is used
to reduce pain that occurs during and after the above procedure.
Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures
Completed
Richard C Reznichek, MD
Phase 1
2013-02-01
The purpose of this study is to assess the safety and efficacy of intranasally-administrated
fentanyl pectin spray (Lazanda®)given to decrease the pain during cystoscopy (the passage of
a telescopic instrument into the bladder for purpose of diagnosing the cause of blood in the
urine, urinary complaints or any other problems with the urinary bladder). The current
standard practice is to use Lidocaine jelly (a local anesthetic) given through the urethra to
lubricate and decrease local pain. In this study, an additional medicine (Lazanda®) is used
to reduce pain that occurs during and after the above procedure.
Fentanyl for Breakthrough Pain in the Emergency Department
Terminated
Archimedes Pharma US, Inc.
Phase 4
2014-01-10
The goal of this clinical research study is to learn if fentanyl nasal spray can help
decrease pain related to cancer when used with other drugs for pain. Researchers also want to
know if this drug can help decrease the length of your stay in the Emergency Department.
In this study, fentanyl nasal spray will be compared to a placebo nasal spray. A placebo is
not a drug. It looks like the study drug but it is not designed to treat any disease or
illness. It is designed in this study to be compared with the study spray to learn if the
study spray has any real effect.
You will also be given intravenous (IV) pain drugs. You will be given these drugs even if you
decide not to take part in this study.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
